Augmented IgG anti-acetylcholine receptor response following chronic penicillamine administration.
A model of D-penicillamine (DP) induced myasthenia gravis (MG) was developed in which the anti-acetylcholine receptor (anti-AChR) antibody response to AChR challenge was increased in mice chronically treated with DP. To investigate the mechanism of the DP induced increase, IgM and IgG anti-AChR responses to AChR challenge were studied. IgG responses were significantly greater in the DP treated mice than in the control group while IgM responses were not significantly different. This change appeared to be relatively specific for the AChR response because neither serum immunoglobulin levels nor the IgG response to a second antigen (purified protein derivative) were increased by DP treatment. These results suggest that a specific sensitization to AChR occurs during chronic DP treatment.
Bever
C T
CT
Research Service, DVAMC, Memphis, TN.
Asofsky
R
R
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D005260:Female; D007074:Immunoglobulin G / Q000276:immunology / Q000378:metabolism*; D007075:Immunoglobulin M / Q000276:immunology / Q000378:metabolism; D007136:Immunoglobulins / Q000032:analysis; D051379:Mice; D008810:Mice, Inbred C57BL; D010396:Penicillamine / Q000008:administration & dosage* / Q000494:pharmacology; D051381:Rats; D011950:Receptors, Cholinergic / Q000276:immunology*; D013997:Time Factors; D014373:Tuberculin / Q000276:immunology
D000906:Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D011950:Receptors, Cholinergic; D014373:Tuberculin; D010396:Penicillamine